Dalfampridine | Interleukin Related interleukin-related.com

Product Name :
Dalfampridine

Search keywords :
4-Aminopyridine

drugId :
null

Target Vo:
Potassium channel

Target Vo Short Name :
Potassium channel

Moa_Name:
Potassium channel blockers

First Approval Country :
United States

First Approval Date Filter:
2010

Origin Company_Name :
Acorda Therapeutics Inc

Active Company_Name :
Acorda Therapeutics Inc

Active Indication_Name:
Multiple Sclerosis

In Active Indication_Name:
Multiple Sclerosis, Relapsing-Remitting

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Benralizumab MedChemExpress
PU.1 Rabbit mAb MedChemExpress
FGFR1 Antibody: FGFR1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 100,140 kDa, targeting to FGFR1. It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts